Global Biosimilar Monoclonal Antibodies Market Insights and Forecast to 2031

Report ID: 854956 | Published Date: Jan 2025 | No. of Page: 110 | Base Year: 2024 | Rating: 4 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Study Coverage
    1.1 Biosimilar Monoclonal Antibodies Product Introduction
    1.2 Market by Type
        1.2.1 Global Biosimilar Monoclonal Antibodies Market Size Growth Rate by Type
        1.4.2 Infliximab
        1.4.3 Rituximab
        1.2.4 Trastuzumab
        1.2.5 Adalimumab
        1.2.6 Other
    1.3 Market by Application
        1.3.1 Global Biosimilar Monoclonal Antibodies Market Size Growth Rate by Application
        1.3.2 Oncology
        1.3.3 Autoimmune Disease
        1.3.4 Other
1.4 Study Objectives
1.5 Years Considered

2 Executive Summary
    2.1 Global Biosimilar Monoclonal Antibodies Sales Estimates and Forecasts 2016-2027
    2.2 Global Biosimilar Monoclonal Antibodies Revenue Estimates and Forecasts 2016-2027
    2.3 Global Biosimilar Monoclonal Antibodies Revenue by Region: 2016 VS 2021 VS 2027
    2.4 Global Top Biosimilar Monoclonal Antibodies Regions by Sales
        2.4.1 Global Top Biosimilar Monoclonal Antibodies Regions by Sales (2016-2021)
        2.4.2 Global Top Biosimilar Monoclonal Antibodies Regions by Sales (2022-2027)
    2.5 Global Top Biosimilar Monoclonal Antibodies Regions by Revenue
        2.5.1 Global Top Biosimilar Monoclonal Antibodies Regions by Revenue (2016-2021)
        2.5.2 Global Top Biosimilar Monoclonal Antibodies Regions by Revenue (2022-2027)
    2.6 North America
    2.7 Europe
    2.8 Asia-Pacific
    2.9 Latin America
    2.10 Middle East & Africa
3 Competition by Manufacturers
    3.1 Global Biosimilar Monoclonal Antibodies Sales by Manufacturers
        3.1.1 Global Top Biosimilar Monoclonal Antibodies Manufacturers by Sales (2016-2021)
        3.1.2 Global Top Biosimilar Monoclonal Antibodies Manufacturers Market Share by Sales (2016-2021)
        3.1.3 Global Top 10 and Top 5 Companies by Biosimilar Monoclonal Antibodies Sales in 2020
    3.2 Global Biosimilar Monoclonal Antibodies Revenue by Manufacturers
        3.2.1 Global Top Biosimilar Monoclonal Antibodies Manufacturers by Revenue (2016-2021)
        3.2.2 Global Top Biosimilar Monoclonal Antibodies Manufacturers Market Share by Revenue (2016-2021)
        3.2.3 Global Top 10 and Top 5 Companies by Biosimilar Monoclonal Antibodies Revenue in 2020
    3.3 Global Biosimilar Monoclonal Antibodies Sales Price by Manufacturers
    3.4 Analysis of Competitive Landscape
        3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Biosimilar Monoclonal Antibodies Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
        3.4.3 Global Biosimilar Monoclonal Antibodies Manufacturers Geographical Distribution
    3.5 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type
    4.1 Global Biosimilar Monoclonal Antibodies Sales by Type
        4.1.1 Global Biosimilar Monoclonal Antibodies Historical Sales by Type (2016-2021)
        4.1.2 Global Biosimilar Monoclonal Antibodies Forecasted Sales by Type (2022-2027)
        4.1.3 Global Biosimilar Monoclonal Antibodies Sales Market Share by Type (2016-2027)
    4.2 Global Biosimilar Monoclonal Antibodies Revenue by Type
        4.2.1 Global Biosimilar Monoclonal Antibodies Historical Revenue by Type (2016-2021)
        4.2.2 Global Biosimilar Monoclonal Antibodies Forecasted Revenue by Type (2022-2027)
        4.2.3 Global Biosimilar Monoclonal Antibodies Revenue Market Share by Type (2016-2027)
    4.3 Global Biosimilar Monoclonal Antibodies Price by Type
        4.3.1 Global Biosimilar Monoclonal Antibodies Price by Type (2016-2021)
        4.3.2 Global Biosimilar Monoclonal Antibodies Price Forecast by Type (2022-2027)
5 Market Size by Application
    5.1 Global Biosimilar Monoclonal Antibodies Sales by Application
        5.1.1 Global Biosimilar Monoclonal Antibodies Historical Sales by Application (2016-2021)
        5.1.2 Global Biosimilar Monoclonal Antibodies Forecasted Sales by Application (2022-2027)
        5.1.3 Global Biosimilar Monoclonal Antibodies Sales Market Share by Application (2016-2027)
    5.2 Global Biosimilar Monoclonal Antibodies Revenue by Application
        5.2.1 Global Biosimilar Monoclonal Antibodies Historical Revenue by Application (2016-2021)
        5.2.2 Global Biosimilar Monoclonal Antibodies Forecasted Revenue by Application (2022-2027)
        5.2.3 Global Biosimilar Monoclonal Antibodies Revenue Market Share by Application (2016-2027)
    5.3 Global Biosimilar Monoclonal Antibodies Price by Application
        5.3.1 Global Biosimilar Monoclonal Antibodies Price by Application (2016-2021)
        5.3.2 Global Biosimilar Monoclonal Antibodies Price Forecast by Application (2022-2027)

6 North America
    6.1 North America Biosimilar Monoclonal Antibodies Market Size by Type
        6.1.1 North America Biosimilar Monoclonal Antibodies Sales by Type (2016-2027)
        6.1.2 North America Biosimilar Monoclonal Antibodies Revenue by Type (2016-2027)
    6.2 North America Biosimilar Monoclonal Antibodies Market Size by Application
        6.2.1 North America Biosimilar Monoclonal Antibodies Sales by Application (2016-2027)
        6.2.2 North America Biosimilar Monoclonal Antibodies Revenue by Application (2016-2027)
    6.3 North America Biosimilar Monoclonal Antibodies Market Size by Country
        6.3.1 North America Biosimilar Monoclonal Antibodies Sales by Country (2016-2027)
        6.3.2 North America Biosimilar Monoclonal Antibodies Revenue by Country (2016-2027)
        6.3.3 U.S.
        6.3.4 Canada
7 Europe
    7.1 Europe Biosimilar Monoclonal Antibodies Market Size by Type
        7.1.1 Europe Biosimilar Monoclonal Antibodies Sales by Type (2017-2027)
        7.1.2 Europe Biosimilar Monoclonal Antibodies Revenue by Type (2017-2027)
    7.2 Europe Biosimilar Monoclonal Antibodies Market Size by Application
        7.2.1 Europe Biosimilar Monoclonal Antibodies Sales by Application (2017-2027)
        7.2.2 Europe Biosimilar Monoclonal Antibodies Revenue by Application (2017-2027)
    7.3 Europe Biosimilar Monoclonal Antibodies Market Size by Country
        7.3.1 Europe Biosimilar Monoclonal Antibodies Sales by Country (2017-2027)
        7.3.2 Europe Biosimilar Monoclonal Antibodies Revenue by Country (2017-2027)
        7.3.3 Germany
        7.3.4 France
        7.3.5 U.K.
        7.3.6 Italy
        7.3.7 Russia
8 Asia Pacific
    8.1 Asia Pacific Biosimilar Monoclonal Antibodies Market Size by Type
        8.1.1 Asia Pacific Biosimilar Monoclonal Antibodies Sales by Type (2018-2027)
        8.1.2 Asia Pacific Biosimilar Monoclonal Antibodies Revenue by Type (2018-2027)
    8.2 Asia Pacific Biosimilar Monoclonal Antibodies Market Size by Application
        8.2.1 Asia Pacific Biosimilar Monoclonal Antibodies Sales by Application (2018-2027)
        8.2.2 Asia Pacific Biosimilar Monoclonal Antibodies Revenue by Application (2018-2027)
    8.3 Asia Pacific Biosimilar Monoclonal Antibodies Market Size by Region
        8.3.1 Asia Pacific Biosimilar Monoclonal Antibodies Sales by Region (2018-2027)
        8.3.2 Asia Pacific Biosimilar Monoclonal Antibodies Revenue by Region (2018-2027)
        8.3.3 China
        8.3.4 Japan
        8.3.5 South Korea
        8.3.6 India
        8.3.7 Australia
        8.3.8 Taiwan
        8.3.9 Indonesia
        8.3.10 Thailand
        8.3.11 Malaysia
        8.3.12 Philippines
9 Latin America
    9.1 Latin America Biosimilar Monoclonal Antibodies Market Size by Type
        9.1.1 Latin America Biosimilar Monoclonal Antibodies Sales by Type (2019-2027)
        9.1.2 Latin America Biosimilar Monoclonal Antibodies Revenue by Type (2019-2027)
    9.2 Latin America Biosimilar Monoclonal Antibodies Market Size by Application
        9.2.1 Latin America Biosimilar Monoclonal Antibodies Sales by Application (2019-2027)
        9.2.2 Latin America Biosimilar Monoclonal Antibodies Revenue by Application (2019-2027)
    9.3 Latin America Biosimilar Monoclonal Antibodies Market Size by Country
        9.3.1 Latin America Biosimilar Monoclonal Antibodies Sales by Country (2019-2027)
        9.3.2 Latin America Biosimilar Monoclonal Antibodies Revenue by Country (2019-2027)
        9.3.3 Mexico
        9.3.4 Brazil
        9.3.5 Argentina
6 Middle East and Africa
    6.1 Middle East and Africa Biosimilar Monoclonal Antibodies Market Size by Type
        6.1.1 Middle East and Africa Biosimilar Monoclonal Antibodies Sales by Type (2016-2027)
        6.1.2 Middle East and Africa Biosimilar Monoclonal Antibodies Revenue by Type (2016-2027)
    6.2 Middle East and Africa Biosimilar Monoclonal Antibodies Market Size by Application
        6.2.1 Middle East and Africa Biosimilar Monoclonal Antibodies Sales by Application (2016-2027)
        6.2.2 Middle East and Africa Biosimilar Monoclonal Antibodies Revenue by Application (2016-2027)
    6.3 Middle East and Africa Biosimilar Monoclonal Antibodies Market Size by Country
        6.3.1 Middle East and Africa Biosimilar Monoclonal Antibodies Sales by Country (2016-2027)
        6.3.2 Middle East and Africa Biosimilar Monoclonal Antibodies Revenue by Country (2016-2027)
        6.3.3 Turkey
        6.3.4 Saudi Arabia
        6.3.5 U.A.E

11 Company Profiles
    11.1 Celltrion
        11.1.1 Celltrion Corporation Information
        11.1.2 Celltrion Overview
        11.1.3 Celltrion Biosimilar Monoclonal Antibodies Sales, Price, Revenue and Gross Margin (2016-2021)
        11.1.4 Celltrion Biosimilar Monoclonal Antibodies Product Description
        11.1.5 Celltrion Related Developments
    11.2 Pfizer (Hospira)
        11.2.1 Pfizer (Hospira) Corporation Information
        11.2.2 Pfizer (Hospira) Overview
        11.2.3 Pfizer (Hospira) Biosimilar Monoclonal Antibodies Sales, Price, Revenue and Gross Margin (2016-2021)
        11.2.4 Pfizer (Hospira) Biosimilar Monoclonal Antibodies Product Description
        11.2.5 Pfizer (Hospira) Related Developments
    11.3 3SBIO
        11.3.1 3SBIO Corporation Information
        11.3.2 3SBIO Overview
        11.3.3 3SBIO Biosimilar Monoclonal Antibodies Sales, Price, Revenue and Gross Margin (2016-2021)
        11.3.4 3SBIO Biosimilar Monoclonal Antibodies Product Description
        11.3.5 3SBIO Related Developments
    11.4 Novartis (Sandoz)
        11.4.1 Novartis (Sandoz) Corporation Information
        11.4.2 Novartis (Sandoz) Overview
        11.4.3 Novartis (Sandoz) Biosimilar Monoclonal Antibodies Sales, Price, Revenue and Gross Margin (2016-2021)
        11.4.4 Novartis (Sandoz) Biosimilar Monoclonal Antibodies Product Description
        11.4.5 Novartis (Sandoz) Related Developments
    11.5 Dr Reddy’s
        11.5.1 Dr Reddy’s Corporation Information
        11.5.2 Dr Reddy’s Overview
        11.5.3 Dr Reddy’s Biosimilar Monoclonal Antibodies Sales, Price, Revenue and Gross Margin (2016-2021)
        11.5.4 Dr Reddy’s Biosimilar Monoclonal Antibodies Product Description
        11.5.5 Dr Reddy’s Related Developments
    11.6 Celgen Biopharma
        11.6.1 Celgen Biopharma Corporation Information
        11.6.2 Celgen Biopharma Overview
        11.6.3 Celgen Biopharma Biosimilar Monoclonal Antibodies Sales, Price, Revenue and Gross Margin (2016-2021)
        11.6.4 Celgen Biopharma Biosimilar Monoclonal Antibodies Product Description
        11.6.5 Celgen Biopharma Related Developments
    11.7 Cadila Healthcare
        11.7.1 Cadila Healthcare Corporation Information
        11.7.2 Cadila Healthcare Overview
        11.7.3 Cadila Healthcare Biosimilar Monoclonal Antibodies Sales, Price, Revenue and Gross Margin (2016-2021)
        11.7.4 Cadila Healthcare Biosimilar Monoclonal Antibodies Product Description
        11.7.5 Cadila Healthcare Related Developments
    11.8 Hisun Pharma
        11.8.1 Hisun Pharma Corporation Information
        11.8.2 Hisun Pharma Overview
        11.8.3 Hisun Pharma Biosimilar Monoclonal Antibodies Sales, Price, Revenue and Gross Margin (2016-2021)
        11.8.4 Hisun Pharma Biosimilar Monoclonal Antibodies Product Description
        11.8.5 Hisun Pharma Related Developments
    11.9 Torrent Pharmaceuticals
        11.9.1 Torrent Pharmaceuticals Corporation Information
        11.9.2 Torrent Pharmaceuticals Overview
        11.9.3 Torrent Pharmaceuticals Biosimilar Monoclonal Antibodies Sales, Price, Revenue and Gross Margin (2016-2021)
        11.9.4 Torrent Pharmaceuticals Biosimilar Monoclonal Antibodies Product Description
        11.9.5 Torrent Pharmaceuticals Related Developments
    11.1 Celltrion
        11.1.1 Celltrion Corporation Information
        11.1.2 Celltrion Overview
        11.1.3 Celltrion Biosimilar Monoclonal Antibodies Sales, Price, Revenue and Gross Margin (2016-2021)
        11.1.4 Celltrion Biosimilar Monoclonal Antibodies Product Description
        11.1.5 Celltrion Related Developments

12 Value Chain and Sales Channels Analysis
    12.1 Biosimilar Monoclonal Antibodies Value Chain Analysis
    12.2 Biosimilar Monoclonal Antibodies Key Raw Materials
        12.2.1 Key Raw Materials
        12.2.2 Raw Materials Key Suppliers
    12.3 Biosimilar Monoclonal Antibodies Production Mode & Process
    12.4 Biosimilar Monoclonal Antibodies Sales and Marketing
        12.4.1 Biosimilar Monoclonal Antibodies Sales Channels
        12.4.2 Biosimilar Monoclonal Antibodies Distributors
    12.5 Biosimilar Monoclonal Antibodies Customers

13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
    13.1 Biosimilar Monoclonal Antibodies Industry Trends
    13.2 Biosimilar Monoclonal Antibodies Market Drivers
    13.3 Biosimilar Monoclonal Antibodies Market Challenges
    13.4 Biosimilar Monoclonal Antibodies Market Restraints

14 Key Findings in The Global Biosimilar Monoclonal Antibodies Study
15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
        15.1.2 Data Source
    15.2 Author Details
    15.3 Disclaimer
List of Tables
    Table 1. Global Biosimilar Monoclonal Antibodies Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
    Table 2. Major Manufacturers of Infliximab
    Table 3. Major Manufacturers of Rituximab
    Table 4. Major Manufacturers of Trastuzumab
    Table 5. Major Manufacturers of Adalimumab
    Table 6. Major Manufacturers of Other
    Table 7. Global Biosimilar Monoclonal Antibodies Market Size Growth Rate by Application, 2016 VS 2021 VS 2027 (US$ Million)
    Table 8. Global Biosimilar Monoclonal Antibodies Revenue by Region: 2016 VS 2021 VS 2027 (US$ Million)
    Table 9. Global Biosimilar Monoclonal Antibodies Sales by Region (2016-2021) & (K Units)
    Table 10. Global Biosimilar Monoclonal Antibodies Sales Market Share by Region (2016-2021)
    Table 11. Global Biosimilar Monoclonal Antibodies Sales by Region (2016-2021) & (K Units)
    Table 12. Global Biosimilar Monoclonal Antibodies Sales Market Share by Region (2022-2027)
    Table 13. Global Biosimilar Monoclonal Antibodies Revenue by Region (2016-2021) & (US$ Million)
    Table 14. Global Biosimilar Monoclonal Antibodies Revenue Market Share by Region (2016-2021)
    Table 15. Global Biosimilar Monoclonal Antibodies Revenue by Region (2022-2027) & (US$ Million)
    Table 16. Global Biosimilar Monoclonal Antibodies Revenue Market Share by Region (2022-2027)
    Table 17. Global Biosimilar Monoclonal Antibodies Sales by Manufacturers (2016-2021) & (K Units)
    Table 18. Global Biosimilar Monoclonal Antibodies Sales Share by Manufacturers (2016-2021)
    Table 19. Global Biosimilar Monoclonal Antibodies Revenue by Manufacturers (2016-2021) & (US$ Million)
    Table 20. Global Biosimilar Monoclonal Antibodies Revenue Share by Manufacturers (2016-2021)
    Table 21. Biosimilar Monoclonal Antibodies Price by Manufacturers 2016-2021 (USD/Unit)
    Table 22. Global Biosimilar Monoclonal Antibodies Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 23. Global Biosimilar Monoclonal Antibodies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biosimilar Monoclonal Antibodies as of 2020)
    Table 24. Biosimilar Monoclonal Antibodies Manufacturing Base Distribution and Headquarters
    Table 25. Manufacturers Biosimilar Monoclonal Antibodies Product Offered
    Table 26. Date of Manufacturers Enter into Biosimilar Monoclonal Antibodies Market
    Table 27. Mergers & Acquisitions, Expansion Plans
    Table 28. Global Biosimilar Monoclonal Antibodies Sales by Type (2016-2021) & (K Units)
    Table 29. Global Biosimilar Monoclonal Antibodies Sales by Type (2022-2027) & (K Units)
    Table 30. Global Biosimilar Monoclonal Antibodies Sales Share by Type (2016-2021)
    Table 31. Global Biosimilar Monoclonal Antibodies Sales Share by Type (2022-2027)
    Table 32. Global Biosimilar Monoclonal Antibodies Revenue by Type (2016-2021) & (US$ Million)
    Table 33. Global Biosimilar Monoclonal Antibodies Revenue by Type (2022-2027) & (US$ Million)
    Table 34. Global Biosimilar Monoclonal Antibodies Revenue Share by Type (2016-2021)
    Table 35. Global Biosimilar Monoclonal Antibodies Revenue Share by Type (2022-2027)
    Table 36. Biosimilar Monoclonal Antibodies Price by Type (2016-2021) & (USD/Unit)
    Table 37. Global Biosimilar Monoclonal Antibodies Price Forecast by Type (2022-2027) & (USD/Unit)
    Table 38. Global Biosimilar Monoclonal Antibodies Sales by Application (2016-2021) & (K Units)
    Table 39. Global Biosimilar Monoclonal Antibodies Sales by Application (2022-2027) & (K Units)
    Table 40. Global Biosimilar Monoclonal Antibodies Sales Share by Application (2016-2021)
    Table 41. Global Biosimilar Monoclonal Antibodies Sales Share by Application (2022-2027)
    Table 42. Global Biosimilar Monoclonal Antibodies Revenue by Application (2016-2021) & (US$ Million)
    Table 43. Global Biosimilar Monoclonal Antibodies Revenue by Application (2022-2027) & (US$ Million)
    Table 44. Global Biosimilar Monoclonal Antibodies Revenue Share by Application (2016-2021)
    Table 45. Global Biosimilar Monoclonal Antibodies Revenue Share by Application (2022-2027)
    Table 46. Biosimilar Monoclonal Antibodies Price by Application (2016-2021) & (USD/Unit)
    Table 47. Global Biosimilar Monoclonal Antibodies Price Forecast by Application (2022-2027) & (USD/Unit)
    Table 48. North America Biosimilar Monoclonal Antibodies Sales by Type (2016-2021) & (K Units)
    Table 49. North America Biosimilar Monoclonal Antibodies Sales by Type (2022-2027) & (K Units)
    Table 50. North America Biosimilar Monoclonal Antibodies Revenue by Type (2016-2021) & (US$ Million)
    Table 51. North America Biosimilar Monoclonal Antibodies Revenue by Type (2022-2027) & (US$ Million)
    Table 52. North America Biosimilar Monoclonal Antibodies Sales by Application (2016-2021) & (K Units)
    Table 53. North America Biosimilar Monoclonal Antibodies Sales by Application (2022-2027) & (K Units)
    Table 54. North America Biosimilar Monoclonal Antibodies Revenue by Application (2016-2021) & (US$ Million)
    Table 55. North America Biosimilar Monoclonal Antibodies Revenue by Application (2022-2027) & (US$ Million)
    Table 56. North America Biosimilar Monoclonal Antibodies Sales by Country (2016-2021) & (K Units)
    Table 57. North America Biosimilar Monoclonal Antibodies Sales by Country (2022-2027) & (K Units)
    Table 58. North America Biosimilar Monoclonal Antibodies Revenue by Country (2016-2021) & (US$ Million)
    Table 59. North America Biosimilar Monoclonal Antibodies Revenue by Country (2022-2027) & (US$ Million)
    Table 60. Europe Biosimilar Monoclonal Antibodies Sales by Type (2016-2021) & (K Units)
    Table 61. Europe Biosimilar Monoclonal Antibodies Sales by Type (2022-2027) & (K Units)
    Table 62. Europe Biosimilar Monoclonal Antibodies Revenue by Type (2016-2021) & (US$ Million)
    Table 63. Europe Biosimilar Monoclonal Antibodies Revenue by Type (2022-2027) & (US$ Million)
    Table 64. Europe Biosimilar Monoclonal Antibodies Sales by Application (2016-2021) & (K Units)
    Table 65. Europe Biosimilar Monoclonal Antibodies Sales by Application (2022-2027) & (K Units)
    Table 66. Europe Biosimilar Monoclonal Antibodies Revenue by Application (2016-2021) & (US$ Million)
    Table 67. Europe Biosimilar Monoclonal Antibodies Revenue by Application (2022-2027) & (US$ Million)
    Table 68. Europe Biosimilar Monoclonal Antibodies Sales by Country (2016-2021) & (K Units)
    Table 69. Europe Biosimilar Monoclonal Antibodies Sales by Country (2022-2027) & (K Units)
    Table 70. Europe Biosimilar Monoclonal Antibodies Revenue by Country (2016-2021) & (US$ Million)
    Table 71. Europe Biosimilar Monoclonal Antibodies Revenue by Country (2022-2027) & (US$ Million)
    Table 72. Asia Pacific Biosimilar Monoclonal Antibodies Sales by Type (2016-2021) & (K Units)
    Table 73. Asia Pacific Biosimilar Monoclonal Antibodies Sales by Type (2022-2027) & (K Units)
    Table 74. Asia Pacific Biosimilar Monoclonal Antibodies Revenue by Type (2016-2021) & (US$ Million)
    Table 75. Asia Pacific Biosimilar Monoclonal Antibodies Revenue by Type (2022-2027) & (US$ Million)
    Table 76. Asia Pacific Biosimilar Monoclonal Antibodies Sales by Application (2016-2021) & (K Units)
    Table 77. Asia Pacific Biosimilar Monoclonal Antibodies Sales by Application (2022-2027) & (K Units)
    Table 78. Asia Pacific Biosimilar Monoclonal Antibodies Revenue by Application (2016-2021) & (US$ Million)
    Table 79. Asia Pacific Biosimilar Monoclonal Antibodies Revenue by Application (2022-2027) & (US$ Million)
    Table 80. Asia Pacific Biosimilar Monoclonal Antibodies Sales by Region (2016-2021) & (K Units)
    Table 81. Asia Pacific Biosimilar Monoclonal Antibodies Sales by Region (2022-2027) & (K Units)
    Table 82. Asia Pacific Biosimilar Monoclonal Antibodies Revenue by Region (2016-2021) & (US$ Million)
    Table 83. Asia Pacific Biosimilar Monoclonal Antibodies Revenue by Region (2022-2027) & (US$ Million)
    Table 84. Latin America Biosimilar Monoclonal Antibodies Sales by Type (2016-2021) & (K Units)
    Table 85. Latin America Biosimilar Monoclonal Antibodies Sales by Type (2022-2027) & (K Units)
    Table 86. Latin America Biosimilar Monoclonal Antibodies Revenue by Type (2016-2021) & (US$ Million)
    Table 87. Latin America Biosimilar Monoclonal Antibodies Revenue by Type (2022-2027) & (US$ Million)
    Table 88. Latin America Biosimilar Monoclonal Antibodies Sales by Application (2016-2021) & (K Units)
    Table 89. Latin America Biosimilar Monoclonal Antibodies Sales by Application (2022-2027) & (K Units)
    Table 90. Latin America Biosimilar Monoclonal Antibodies Revenue by Application (2016-2021) & (US$ Million)
    Table 91. Latin America Biosimilar Monoclonal Antibodies Revenue by Application (2022-2027) & (US$ Million)
    Table 92. Latin America Biosimilar Monoclonal Antibodies Sales by Country (2016-2021) & (K Units)
    Table 93. Latin America Biosimilar Monoclonal Antibodies Sales by Country (2022-2027) & (K Units)
    Table 94. Latin America Biosimilar Monoclonal Antibodies Revenue by Country (2016-2021) & (US$ Million)
    Table 95. Latin America Biosimilar Monoclonal Antibodies Revenue by Country (2022-2027) & (US$ Million)
    Table 96. Middle East and Africa Biosimilar Monoclonal Antibodies Sales by Type (2016-2021) & (K Units)
    Table 97. Middle East and Africa Biosimilar Monoclonal Antibodies Sales by Type (2022-2027) & (K Units)
    Table 98. Middle East and Africa Biosimilar Monoclonal Antibodies Revenue by Type (2016-2021) & (US$ Million)
    Table 99. Middle East and Africa Biosimilar Monoclonal Antibodies Revenue by Type (2022-2027) & (US$ Million)
    Table 100. Middle East and Africa Biosimilar Monoclonal Antibodies Sales by Application (2016-2021) & (K Units)
    Table 101. Middle East and Africa Biosimilar Monoclonal Antibodies Sales by Application (2022-2027) & (K Units)
    Table 102. Middle East and Africa Biosimilar Monoclonal Antibodies Revenue by Application (2016-2021) & (US$ Million)
    Table 103. Middle East and Africa Biosimilar Monoclonal Antibodies Revenue by Application (2022-2027) & (US$ Million)
    Table 104. Middle East and Africa Biosimilar Monoclonal Antibodies Sales by Country (2016-2021) & (K Units)
    Table 105. Middle East and Africa Biosimilar Monoclonal Antibodies Sales by Country (2022-2027) & (K Units)
    Table 106. Middle East and Africa Biosimilar Monoclonal Antibodies Revenue by Country (2016-2021) & (US$ Million)
    Table 107. Middle East and Africa Biosimilar Monoclonal Antibodies Revenue by Country (2022-2027) & (US$ Million)
    Table 108. Celltrion Corporation Information
    Table 109. Celltrion Description and Major Businesses
    Table 110. Celltrion Biosimilar Monoclonal Antibodies Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
    Table 111. Celltrion Biosimilar Monoclonal Antibodies Product
    Table 112. Celltrion Recent Developments
    Table 113. Pfizer (Hospira) Corporation Information
    Table 114. Pfizer (Hospira) Description and Major Businesses
    Table 115. Pfizer (Hospira) Biosimilar Monoclonal Antibodies Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
    Table 116. Pfizer (Hospira) Biosimilar Monoclonal Antibodies Product
    Table 117. Pfizer (Hospira) Recent Developments
    Table 118. 3SBIO Corporation Information
    Table 119. 3SBIO Description and Major Businesses
    Table 120. 3SBIO Biosimilar Monoclonal Antibodies Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
    Table 121. 3SBIO Biosimilar Monoclonal Antibodies Product
    Table 122. 3SBIO Recent Developments
    Table 123. Novartis (Sandoz) Corporation Information
    Table 124. Novartis (Sandoz) Description and Major Businesses
    Table 125. Novartis (Sandoz) Biosimilar Monoclonal Antibodies Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
    Table 126. Novartis (Sandoz) Biosimilar Monoclonal Antibodies Product
    Table 127. Novartis (Sandoz) Recent Developments
    Table 128. Dr Reddy’s Corporation Information
    Table 129. Dr Reddy’s Description and Major Businesses
    Table 130. Dr Reddy’s Biosimilar Monoclonal Antibodies Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
    Table 131. Dr Reddy’s Biosimilar Monoclonal Antibodies Product
    Table 132. Dr Reddy’s Recent Developments
    Table 133. Celgen Biopharma Corporation Information
    Table 134. Celgen Biopharma Description and Major Businesses
    Table 135. Celgen Biopharma Biosimilar Monoclonal Antibodies Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
    Table 136. Celgen Biopharma Biosimilar Monoclonal Antibodies Product
    Table 137. Celgen Biopharma Recent Developments
    Table 138. Cadila Healthcare Corporation Information
    Table 139. Cadila Healthcare Description and Major Businesses
    Table 140. Cadila Healthcare Biosimilar Monoclonal Antibodies Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
    Table 141. Cadila Healthcare Biosimilar Monoclonal Antibodies Product
    Table 142. Cadila Healthcare Recent Developments
    Table 143. Hisun Pharma Corporation Information
    Table 144. Hisun Pharma Description and Major Businesses
    Table 145. Hisun Pharma Biosimilar Monoclonal Antibodies Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
    Table 146. Hisun Pharma Biosimilar Monoclonal Antibodies Product
    Table 147. Hisun Pharma Recent Developments
    Table 148. Torrent Pharmaceuticals Corporation Information
    Table 149. Torrent Pharmaceuticals Description and Major Businesses
    Table 150. Torrent Pharmaceuticals Biosimilar Monoclonal Antibodies Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
    Table 151. Torrent Pharmaceuticals Biosimilar Monoclonal Antibodies Product
    Table 152. Torrent Pharmaceuticals Recent Developments
    Table 153. Key Raw Materials Lists
    Table 154. Raw Materials Key Suppliers Lists
    Table 155. Biosimilar Monoclonal Antibodies Distributors List
    Table 156. Biosimilar Monoclonal Antibodies Customers List
    Table 157. Biosimilar Monoclonal Antibodies Market Trends
    Table 158. Biosimilar Monoclonal Antibodies Market Drivers
    Table 159. Biosimilar Monoclonal Antibodies Market Challenges
    Table 160. Biosimilar Monoclonal Antibodies Market Restraints
    Table 161. Research Programs/Design for This Report
    Table 162. Key Data Information from Secondary Sources
    Table 163. Key Data Information from Primary Sources
List of Figures
    Figure 1. Biosimilar Monoclonal Antibodies Product Picture
    Figure 2. Global Biosimilar Monoclonal Antibodies Market Share by Type in 2020 & 2027
    Figure 3. Infliximab Product Picture
    Figure 4. Rituximab Product Picture
    Figure 5. Trastuzumab Product Picture
    Figure 6. Adalimumab Product Picture
    Figure 7. Other Product Picture
    Figure 8. Global Biosimilar Monoclonal Antibodies Sales Market Share by Application in 2020 & 2027
    Figure 9. Oncology
    Figure 10. Autoimmune Disease
    Figure 11. Other
    Figure 12. Biosimilar Monoclonal Antibodies Report Years Considered
    Figure 13. Global Biosimilar Monoclonal Antibodies Sales 2016-2027 (K Units)
    Figure 14. Global Biosimilar Monoclonal Antibodies Revenue, (US$ Million), 2016 VS 2021 VS 2027
    Figure 15. Global Biosimilar Monoclonal Antibodies Revenue 2016-2027 (US$ Million)
    Figure 16. Global Biosimilar Monoclonal Antibodies Revenue Market Share by Region in Percentage: 2020 Versus 2027
    Figure 17. Global Biosimilar Monoclonal Antibodies Sales Market Share by Region (2016-2021)
    Figure 18. Global Biosimilar Monoclonal Antibodies Sales Market Share by Region (2022-2027)
    Figure 19. North America Biosimilar Monoclonal Antibodies Sales YoY (2016-2027) & (K Units)
    Figure 20. North America Biosimilar Monoclonal Antibodies Revenue YoY (2016-2027) & (US$ Million)
    Figure 21. Europe Biosimilar Monoclonal Antibodies Sales YoY (2016-2027) & (K Units)
    Figure 22. Europe Biosimilar Monoclonal Antibodies Revenue YoY (2016-2027) & (US$ Million)
    Figure 23. Asia-Pacific Biosimilar Monoclonal Antibodies Sales YoY (2016-2027) & (K Units)
    Figure 24. Asia-Pacific Biosimilar Monoclonal Antibodies Revenue YoY (2016-2027) & (US$ Million)
    Figure 25. Latin America Biosimilar Monoclonal Antibodies Sales YoY (2016-2027) & (K Units)
    Figure 26. Latin America Biosimilar Monoclonal Antibodies Revenue YoY (2016-2027) & (US$ Million)
    Figure 27. Middle East & Africa Biosimilar Monoclonal Antibodies Sales YoY (2016-2027) & (K Units)
    Figure 28. Middle East & Africa Biosimilar Monoclonal Antibodies Revenue YoY (2016-2027) & (US$ Million)
    Figure 29. The Top 10 and Top 5 Players Market Share by Biosimilar Monoclonal Antibodies Sales in 2020
    Figure 30. The Top 10 and Top 5 Players Market Share by Biosimilar Monoclonal Antibodies Revenue in 2020
    Figure 31. Biosimilar Monoclonal Antibodies Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2016 VS 2020
    Figure 32. Global Biosimilar Monoclonal Antibodies Sales Market Share by Type (2016-2027)
    Figure 33. Global Biosimilar Monoclonal Antibodies Revenue Market Share by Type (2016-2027)
    Figure 34. Global Biosimilar Monoclonal Antibodies Sales Market Share by Application (2016-2027)
    Figure 35. Global Biosimilar Monoclonal Antibodies Revenue Market Share by Application (2016-2027)
    Figure 36. North America Biosimilar Monoclonal Antibodies Sales Market Share by Type (2016-2027)
    Figure 37. North America Biosimilar Monoclonal Antibodies Revenue Market Share by Type (2016-2027)
    Figure 38. North America Biosimilar Monoclonal Antibodies Sales Market Share by Application (2016-2027)
    Figure 39. North America Biosimilar Monoclonal Antibodies Revenue Market Share by Application (2016-2027)
    Figure 40. North America Biosimilar Monoclonal Antibodies Sales Share by Country (2016-2027)
    Figure 41. North America Biosimilar Monoclonal Antibodies Revenue Share by Country (2016-2027)
    Figure 42. U.S. Biosimilar Monoclonal Antibodies Revenue (2016-2027) & (US$ Million)
    Figure 43. Canada Biosimilar Monoclonal Antibodies Revenue (2016-2027) & (US$ Million)
    Figure 44. Europe Biosimilar Monoclonal Antibodies Sales Market Share by Type (2016-2027)
    Figure 45. Europe Biosimilar Monoclonal Antibodies Revenue Market Share by Type (2016-2027)
    Figure 46. Europe Biosimilar Monoclonal Antibodies Sales Market Share by Application (2016-2027)
    Figure 47. Europe Biosimilar Monoclonal Antibodies Revenue Market Share by Application (2016-2027)
    Figure 48. Europe Biosimilar Monoclonal Antibodies Sales Share by Country (2016-2027)
    Figure 49. Europe Biosimilar Monoclonal Antibodies Revenue Share by Country (2016-2027)
    Figure 50. Germany Biosimilar Monoclonal Antibodies Revenue (2016-2027) & (US$ Million)
    Figure 51. France Biosimilar Monoclonal Antibodies Revenue (2016-2027) & (US$ Million)
    Figure 52. U.K. Biosimilar Monoclonal Antibodies Revenue (2016-2027) & (US$ Million)
    Figure 53. Italy Biosimilar Monoclonal Antibodies Revenue (2016-2027) & (US$ Million)
    Figure 54. Russia Biosimilar Monoclonal Antibodies Revenue (2016-2027) & (US$ Million)
    Figure 55. Asia Pacific Biosimilar Monoclonal Antibodies Sales Market Share by Type (2016-2027)
    Figure 56. Asia Pacific Biosimilar Monoclonal Antibodies Revenue Market Share by Type (2016-2027)
    Figure 57. Asia Pacific Biosimilar Monoclonal Antibodies Sales Market Share by Application (2016-2027)
    Figure 58. Asia Pacific Biosimilar Monoclonal Antibodies Revenue Market Share by Application (2016-2027)
    Figure 59. Asia Pacific Biosimilar Monoclonal Antibodies Sales Share by Region (2016-2027)
    Figure 60. Asia Pacific Biosimilar Monoclonal Antibodies Revenue Share by Region (2016-2027)
    Figure 61. China Biosimilar Monoclonal Antibodies Revenue (2016-2027) & (US$ Million)
    Figure 62. Japan Biosimilar Monoclonal Antibodies Revenue (2016-2027) & (US$ Million)
    Figure 63. South Korea Biosimilar Monoclonal Antibodies Revenue (2016-2027) & (US$ Million)
    Figure 64. India Biosimilar Monoclonal Antibodies Revenue (2016-2027) & (US$ Million)
    Figure 65. Australia Biosimilar Monoclonal Antibodies Revenue (2016-2027) & (US$ Million)
    Figure 66. Taiwan Biosimilar Monoclonal Antibodies Revenue (2016-2027) & (US$ Million)
    Figure 67. Indonesia Biosimilar Monoclonal Antibodies Revenue (2016-2027) & (US$ Million)
    Figure 68. Thailand Biosimilar Monoclonal Antibodies Revenue (2016-2027) & (US$ Million)
    Figure 69. Malaysia Biosimilar Monoclonal Antibodies Revenue (2016-2027) & (US$ Million)
    Figure 70. Philippines Biosimilar Monoclonal Antibodies Revenue (2016-2027) & (US$ Million)
    Figure 71. Latin America Biosimilar Monoclonal Antibodies Sales Market Share by Type (2016-2027)
    Figure 72. Latin America Biosimilar Monoclonal Antibodies Revenue Market Share by Type (2016-2027)
    Figure 73. Latin America Biosimilar Monoclonal Antibodies Sales Market Share by Application (2016-2027)
    Figure 74. Latin America Biosimilar Monoclonal Antibodies Revenue Market Share by Application (2016-2027)
    Figure 75. Latin America Biosimilar Monoclonal Antibodies Sales Share by Country (2016-2027)
    Figure 76. Latin America Biosimilar Monoclonal Antibodies Revenue Share by Country (2016-2027)
    Figure 77. Mexico Biosimilar Monoclonal Antibodies Revenue (2016-2027) & (US$ Million)
    Figure 78. Brazil Biosimilar Monoclonal Antibodies Revenue (2016-2027) & (US$ Million)
    Figure 79. Argentina Biosimilar Monoclonal Antibodies Revenue (2016-2027) & (US$ Million)
    Figure 80. Middle East and Africa Biosimilar Monoclonal Antibodies Sales Market Share by Type (2016-2027)
    Figure 81. Middle East and Africa Biosimilar Monoclonal Antibodies Revenue Market Share by Type (2016-2027)
    Figure 82. Middle East and Africa Biosimilar Monoclonal Antibodies Sales Market Share by Application (2016-2027)
    Figure 83. Middle East and Africa Biosimilar Monoclonal Antibodies Revenue Market Share by Application (2016-2027)
    Figure 84. Middle East and Africa Biosimilar Monoclonal Antibodies Sales Share by Country (2016-2027)
    Figure 85. Middle East and Africa Biosimilar Monoclonal Antibodies Revenue Share by Country (2016-2027)
    Figure 86. Turkey Biosimilar Monoclonal Antibodies Revenue (2016-2027) & (US$ Million)
    Figure 87. Saudi Arabia Biosimilar Monoclonal Antibodies Revenue (2016-2027) & (US$ Million)
    Figure 88. U.A.E Biosimilar Monoclonal Antibodies Revenue (2016-2027) & (US$ Million)
    Figure 89. Biosimilar Monoclonal Antibodies Value Chain
    Figure 90. Biosimilar Monoclonal Antibodies Production Process
    Figure 91. Channels of Distribution
    Figure 92. Distributors Profiles
    Figure 93. Bottom-up and Top-down Approaches for This Report
    Figure 94. Data Triangulation
    Figure 95. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Celltrion
Pfizer (Hospira)
3SBIO
Novartis (Sandoz)
Dr Reddy’s
Celgen Biopharma
Cadila Healthcare
Hisun Pharma
Torrent Pharmaceuticals
Frequently Asked Questions
Biosimilar Monoclonal Antibodies report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Biosimilar Monoclonal Antibodies report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Biosimilar Monoclonal Antibodies report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Bipolar Membranes

Bipolar membranes carry out the dissociation of water in the presence of an electric field. These ... Read More

Black Pellets

Black Pellets are produced through torrefaction or steam exploded, during which water content, ce ... Read More

Boom Trucks

Boom Trucks are vehicles mounted with telescopic boom crane equipment to lift cargo or workers in ... Read More

Bottle Warmer

Bottle warmers are a kind of small appliances used for heating breast milk or formula milk to an  ... Read More